Reviewing MediciNova (NASDAQ:MNOV) & BioGaia AB (publ) (OTCMKTS:BIOGY)

BioGaia AB (publ) (OTCMKTS:BIOGY) and MediciNova (NASDAQ:MNOV) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability and analyst recommendations.

Insider and Institutional Ownership

9.9% of MediciNova shares are held by institutional investors. 14.0% of MediciNova shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for BioGaia AB (publ) and MediciNova, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioGaia AB (publ)	0	0	0	0	0.00
MediciNova	1	1	3	1	2.67

MediciNova has a consensus target price of $8.33, indicating a potential upside of 536.13%. Given MediciNova’s stronger consensus rating and higher probable upside, analysts plainly believe MediciNova is more favorable than BioGaia AB (publ).

Profitability

This table compares BioGaia AB (publ) and MediciNova’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BioGaia AB (publ)	N/A	N/A	N/A
MediciNova	-1,168.70%	-25.81%	-23.74%

Earnings & Valuation

This table compares BioGaia AB (publ) and MediciNova”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioGaia AB (publ)	N/A	N/A	N/A	$4.20	2.94
MediciNova	$410,000.00	157.26	-$12.00 million	($0.23)	-5.70

BioGaia AB (publ) has higher earnings, but lower revenue than MediciNova. MediciNova is trading at a lower price-to-earnings ratio than BioGaia AB (publ), indicating that it is currently the more affordable of the two stocks.

Summary

MediciNova beats BioGaia AB (publ) on 7 of the 12 factors compared between the two stocks.

About BioGaia AB (publ)

BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is based in Stockholm, Sweden.

About MediciNova

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological and other disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction, as well as prevention of acute respiratory distress syndrome, and long COVID. The company's product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic and other diseases, including nonalcoholic fatty liver disease and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. It has license agreements with Kyorin Pharmaceutical Co., Ltd; Angiogene Pharmaceuticals, Ltd.; and Meiji Seika Kaisha, Ltd. The company was incorporated in 2000 and is headquartered in La Jolla, California.